Onzima Ventures Share Discussion Threads

[someuwin] 08/9/2016 11:00

So the Viagra type market is worth £4.8bn per year.

The reformulated improved version should easily capture 10% of the market so £500m partner (Pfizer?) sales per year.

Of which N4 Pharma would receive say 5% - 10% license fees.

So £40m per year profit on this one drug alone.

...And N4 Pharma have 50 other drug products identified for reformulation!

[keya5000] 08/9/2016 10:44

yes decent sized delayed trade

[keya5000] 08/9/2016 10:37

Strong two way trading in progress, buy side seems to pushing through.

[curlly] 08/9/2016 10:37

That was a large delayed buy

[someuwin] 08/9/2016 10:21

N4 Pharma Ltd is attending this networking event along with some of the world's major drug makers including....

Eli Lilly, GSK, Johnson & Johnson, Bristol Myers Squibb, AstraZeneca, 3M Healthcare etc etc.

Lots of partnering opportunities there.

Bio-Homecoming 2016

A Partnering Event on Drug Discovery and Precision Medicine

September 22, 2016 - Leicester Tigers Stadium

[someuwin] 08/9/2016 10:10

Its going to be another high volume day.

Needs buyers and sellers as the valuation steadily increases.

[keya5000] 08/9/2016 09:59

FUM approaching £90m mcap.

ONZ £3.3m

The potential here is staggering.

[doodlebug4] 08/9/2016 09:53

LOL keya.:-)

[flashheart] 08/9/2016 09:37

The Proton with a positive effect lol. Pleased I topped up earlier.

[sophisticatedtrader] 08/9/2016 09:36

Keya ... and they say size is important lol !!!! ;-)))

[keya5000] 08/9/2016 09:35

Cannot resist.

[keya5000] 08/9/2016 09:34

This is going to break the years high of 1.9 very shortly.

[someuwin] 08/9/2016 09:33

Breaking into new highs.

[sophisticatedtrader] 08/9/2016 09:21

They will have to let this baby go soon...interest growing and pressure building ... imho

[keya5000] 08/9/2016 09:06

volume increasing.

[keya5000] 08/9/2016 09:04

someuwin,

Thats what he told me directly, he felt he could do better here and wanted a greater share of the equity.

[someuwin] 08/9/2016 09:02

Plus the fact that the CEO had built up a drug reformulation company before with Oxford Pharmascience Group.

He knows what to do, and what not to do.

...And with N4 Pharma he sees even more potential!

[keya5000] 08/9/2016 08:55

Someuwin,

Agree 100%, when NT started buying ONZ shares we could not have been given a more positive indicator.

Potential here is staggering.

[someuwin] 08/9/2016 08:42

The real opportunity here is that we are able to buy into a start-up drug development company at what is effectively pre-ipo levels.

If N4 Pharam had done its own listing i'm sure it would have listed with a valuation of £10m or so.

ONZ has become the listed part of N4 (validated by N4 CEO repeatedly buying CEO in the market).

THere are several ways this will play out over the months ahead. But all of them involve a big uplift for current shareholders. imo.

[keya5000] 08/9/2016 08:20

Looking very good, FUM seems to be strong again also which I expect bodes well for us.

The strength and volume early doors is very encouraging.

[flashheart] 07/9/2016 18:39

Hi dB.An interesting play here indeed.Was in this a while back but now got back in as it's an exciting proposition. Good to see some familiar names such as yourself and keya.

[doodlebug4] 07/9/2016 15:54

Agreed keya, as you say FUM is the catalyst right now.

[keya5000] 07/9/2016 15:51

What can I say I like erection drugs (despite not needing such).

LOL....

[cashmachine2] 07/9/2016 15:50

KeyaI see you're also an investor in FUM and after today's news it's excellent news for the sector. I've been looking at ONZ for a period of time and will move funds from FUM after it reaches its potential. After today's news see it multi bagging in a relative timeframe.Good luck.